Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Phibro Animal Health (PAHC) Gains from Investment Securities (2016 - 2025)

Historic Gains from Investment Securities for Phibro Animal Health (PAHC) over the last 13 years, with Q4 2025 value amounting to -$431000.0.

  • Phibro Animal Health's Gains from Investment Securities rose 8660.24% to -$431000.0 in Q4 2025 from the same period last year, while for Dec 2025 it was $21.0 million, marking a year-over-year increase of 5428.63%. This contributed to the annual value of $4.5 million for FY2025, which is 0.0% changed from last year.
  • Latest data reveals that Phibro Animal Health reported Gains from Investment Securities of -$431000.0 as of Q4 2025, which was up 8660.24% from $3.7 million recorded in Q3 2025.
  • Phibro Animal Health's Gains from Investment Securities' 5-year high stood at $19.3 million during Q2 2024, with a 5-year trough of -$3.2 million in Q4 2024.
  • In the last 5 years, Phibro Animal Health's Gains from Investment Securities had a median value of $509500.0 in 2021 and averaged $4.5 million.
  • In the last 5 years, Phibro Animal Health's Gains from Investment Securities skyrocketed by 201538.46% in 2021 and then tumbled by 41035.6% in 2023.
  • Phibro Animal Health's Gains from Investment Securities (Quarter) stood at $1.8 million in 2021, then plummeted by 173.16% to -$1.3 million in 2022, then decreased by 15.62% to -$1.6 million in 2023, then crashed by 107.01% to -$3.2 million in 2024, then soared by 86.6% to -$431000.0 in 2025.
  • Its Gains from Investment Securities stands at -$431000.0 for Q4 2025, versus $3.7 million for Q3 2025 and $17.2 million for Q2 2025.